Analysis of the Association of Administration of various glucocorticoids with development of acute pancreatitis using US Food and Drug Administration adverse event reporting system (FAERS)
Tóm tắt
Từ khóa
Tài liệu tham khảo
Jones MR, Hall OM, Kaye AM, Kaye AD. Drug-induced acute pancreatitis: a review. Ochsner J. 2015;15:45–51.
Okumura H, Miyahara K, Ito K, Koshimura O, Hashimoto K. Review of literature and a case report of steroid pancreatitis. Naika. 1969;23:915–20 (In Japanese).
Jain R, Ramanan SV. Iatrogenic pancreatitis. A fatal complication in the induction therapy for acute lymphocytic leukemia. Arch Intern Med. 1978;138:1726.
Hamed I, Lindeman RD, Czerwinski AW. Case report: Acute pancreatitis following corticosteroid and azathioprine therapy. Am J Med Sci. 1978;276:211–9.
Ossi E, Fiocco U, Belloni M, Ongaro G, Rubaltelli L, Ruffatti A, et al. Therapy of acute pancreatitis in systemic lupus erythematosus with plasmapheresis and corticosteroids. Clin Exp Rheumatol. 1983;1:345–7.
Yoshizawa Y, Ogasa S, Izaki S, Kitamura K. Corticosteroid-induced pancreatitis in patients with autoimmune bullous disease: case report and prospective study. Dermatology. 1999;198:304–6.
Khanna S, Kumar A. Acute pancreatitis due to hydrocortisone in a patient with ulcerative colitis. J Gastroenterol Hepatol 2003;18:1110–1.
Tsuruoka K, Sekiya S, Yokoyama T, Koitabashi K, Shimazaki M, Sakurada T, et al. MPO-ANCA related vasculitis complicating mucinous cystadenoma of the pancreas and severe acute pancreatitis after steroid pulse therapy: a case report. Nihon Jinzo Gakkai Shi. 2008;50:948–53 (in Japanese).
Nishimoto M, Koh H, Bingo M, Yoshida M, Nanno S, Hayashi Y, et al. Posterior reversible encephalopathy syndrome following acute pancreatitis during chemotherapy for acute monocytic leukemia. Rinsho Ketsueki. 2014;55:552–7 (in Japanese).
Sabre A, Guthrie MM, Maleknia R. Acute necrotising pancreatitis derived from low-dose corticosteroid use: an important reminder of clinical management. BMJ Case Reports. 2015. https://doi.org/10.1136/bcr-2015-209325 .
Makol A, Petri M. Pancreatitis in systemic lupus erythematosus: frequency and associated factors-a review of the Hopkins lupus cohort. J Rheumatol. 2010;37:341–5.
Yassin N, Buchler M, Uhl W, Scherbaum WA. Antineutrophil cytoplasmic autoantibodies (ANCA) in acute pancreatitis. Hepato-Gastroenterology. 1992;39:533–5.
Hoffman BI, Katz WA. The gastrointestinal manifestations of systemic lupus erythematosus: a review of the literature. Semin Arthritis Rheum. 1980;9:237–47.
Manuals for ways of coping with severe adverse drug reactions: acute pancreatitis (drug-induced). The Ministry of Labour, Health, and Welfare. 2009. https://www.mhlw.go.jp/topics/2006/11/dl/tp1122-1g13.pdf . Accessed 17 Dec 2018.
Fagenholz PJ, Castillo CF, Harris NS, Pelletier AJ, Camargo CA Jr. Increasing United States hospital admissions for acute pancreatitis, 1988-2003. Ann Epidemiol. 2007;17:491–7.
Anderson V, Sonne J, Anderson M. Spontaneous reports on drug-induced pancreatitis in Denmark from 1968 to 1999. Eur J Clin Pharmacol. 2001;57:517–21.
Rothman KJ, Lanes S, Sacks ST. The reporting odds ratio and its advantages over the proportional reporting ratio. Pharmacoepidemiol Drug Saf. 2004;13:519–23.
Evans SJ, Waller PC, Davis S. Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Saf. 2011;10:483–6.
Van Puijenbroek EP, Bate A, Leufkens HG, Lindquist M, Orre R, Egberts AC. A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions. Pharmacoepidemiol Drug Saf. 2002;11:3–10.
FAERS database US FDA. 2018. http://www.fda.gov/default.htm . Accessed 30 April, 2017.
MedDRA. 2017. https://www.meddra.org/ . Accessed 30 September, 2017.
Nango D, Nakashima H, Hirose Y, Shiina M, Echizen H. Causal relationship between acute pancreatitis and methylprednisolone pulse therapy for fulminant autoimmune hepatitis: a case report and review of literature. J Pharm Health Care Sci. 2018;4:14.
Badalov N, Baradarian R, Iswara K, Li J, Steinberg W, Tenner S. Drug-induced acute pancreatitis: an evidence-based review. Clin Gastroenterol Hepatol. 2007;5:648–61.
Sadr-Azodi O, Mattsson F, Bexlius TS, Lindblad M, Lagergren J, Ljung R, et al. Association of oral glucocorticoid use with an increased risk of acute pancreatitis: a population-based nested case-control study. JAMA Intern Med. 2013;173:444–9.
Montastruc JL, Sommet A, Bagheri H, Lapeyre-Mestre M. Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database. Br J Clin Pharmacol. 2011;72:905–8.
Palleria C, Leporini C, Chimirri S, Marrazzo G, Sacchetta S, Bruno L, et al. Limitations and obstacles of the spontaneous adverse drugs reactions reporting: two “challenging” case reports. J Pharmacol Pharmacother. 2013;4(Suppl 1):S66–72.
Moreau JA, Zinsmeister AR, Melton LJ 3rd, DiMagno EP. Gallstone pancreatitis and the effect of cholecystectomy: a population-based cohort study. Mayo Clin Proc. 1988;63:466–73.
Fortson MR, Freedman SN, Webster PD 3rd. Clinical assessment of hyperlipidemic pancreatitis. Am J Gastroenterol. 1995;90:2134–9.
Martínez J, Sánchez-Payá J, Palazón JM, Suazo-Barahona J, Robles-Díaz G, Pérez-Mateo M. Is obesity a risk factor in acute pancreatitis? A meta-analysis. Pancreatology. 2004;4:42–8.
Venkatesh PG, Navaneethan U. Azathioprine induced pancreatitis in a patient with co-existing autoimmune pancreatitis and hepatitis. JOP. 2011;12:250–4.